What's new

Orphan designation: Givinostat Treatment of Duchenne muscular dystrophy, 04/07/2012 Positive

Orphan designation: Givinostat Treatment of Duchenne muscular dystrophy, 04/07/2012 Positive

Mar 28, 2025 - 11:52
 0
Orphan designation: Givinostat Treatment of Duchenne muscular dystrophy, 04/07/2012 Positive
Orphan designation: Givinostat Treatment of Duchenne muscular dystrophy, 04/07/2012 Positive
Read More

Tags:

Previous Article

Continental equips the Zeekr 001 with PremiumContact 6 tires from the factory

Next Article

Human medicines European public assessment report (EPAR): Cinainu, dry aqueous e...

Related Posts

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

EMEA-000325-PIP01-08-M11

EMEA-000325-PIP01-08-M11

Mar 6, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 February 2025, 10:00 (CET) to 26 February 2025, 12:00 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0